SGLT2 Inhibitor Use Tied to Fewer Atrial Arrhythmias

Patients with cardiac implantable electronic devices who were treated with an SGLT2 inhibitor had significantly fewer atrial arrhythmias vs those never receiving them, new observational data suggest.
Medscape Medical News